Because nadir CD4+ T-cell count was missing in 18 participants and hypertension and hyperlipidemia in 13 participants, follow-up sensitivity analyses were conducted that adjusted for nadir CD4, hypertension and hyperlipidemia to test for any substantive change in results. This evidence concerns the gene CD4 and hypertensive disorder.